Guidelines for treatment and reuse of fermentation-based pharmaceutical wastewater
Introduction: With the development of the social economy and the improvement of people's living standards, the public's demand for drugs to improve the quality of life and prolong lifespan is continually increasing. Pharmaceutical manufacturing ranks among the top five industries in the global economy. Fermentation- based pharmaceuticals, such as analgesics, anti-inflammatory drugs, antibiotics, lipid regulators, receptor blockers and X-ray contrast agents, have been widely used in health treatment. At the same time, the impact of drug pollution and pharmaceutical wastewater discharge has become a global hot topic of concern for environmental protection. At present, traces of drugs have been detected in sewage wastewater, drinking water and rivers in many different places, including the United States, China, Australia, Europe and Africa, and research shows that one of the reasons is the discharge of pharmaceutical wastewater. Pharmaceutical manufacturing is generally divided into two categories: biopharmaceutical production and chemical pharmaceutical production. Fermentation-based pharmaceutical production is one kind of biopharmaceutical production with a long history of development, relatively advanced technology and wide application. Fermentation-based drugs include antibiotics, vitamins, amino acids and other types of drugs. The fermentation pharmaceutical production process not only requires a stable supply of pure water, but also produces a large amount of wastewater. Studies have f
Scope: This document provides technical guidance for fermentation-based pharmaceutical wastewater treatment and reclamation for different reuse purposes. This document contains information on pollution loading, general principles and applicable wastewater treatment and reclamation treatment. In addition, example processes for wastewater treatment and reclamation are listed to support different treatment conditions and reuse purposes.